58 filings
8-K
MIRM
Mirum Pharmaceuticals Inc
8 May 24
Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
4:04pm
8-K
MIRM
Mirum Pharmaceuticals Inc
28 Feb 24
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
4:05pm
8-K
MIRM
Mirum Pharmaceuticals Inc
16 Jan 24
Departure of Directors or Certain Officers
4:15pm
8-K
MIRM
Mirum Pharmaceuticals Inc
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
8-K
MIRM
Mirum Pharmaceuticals Inc
18 Dec 23
Other Events
4:06pm
8-K
fch88s 3j7wo9xpf
2 Nov 23
Results of Operations and Financial Condition
4:06pm
8-K/A
6m6cw2rg 90
2 Nov 23
Financial Statements and Exhibits
4:05pm
8-K
jkw34haxzdzks90q 39c
17 Oct 23
Other Events
4:39pm
8-K
5cskjy 9m3fwa
13 Oct 23
Other Events
4:16pm
8-K
isqv8mhgh
11 Sep 23
Departure of Directors or Certain Officers
4:16pm
8-K
s77 4m75mzo23
5 Sep 23
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics
8:36am
8-K
b21aqgh
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
kgnkh2
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
imzvkvk tqv3t22
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
hdlcxas
13 Jun 23
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
1wzdw6le 2i3
4 May 23
Results of Operations and Financial Condition
4:02pm
8-K
4ae 16mfuf1747
17 Apr 23
Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
4:17pm
8-K
jyzqxz
12 Apr 23
Mirum Pharmaceuticals Announces Preliminary Unaudited First Quarter 2023 Financial Results
6:54am
8-K
hrtte
6 Apr 23
Departure of Directors or Certain Officers
7:31am
8-K
x0esxi6
10 Mar 23
Other Events
5:29pm